Pneumonia hospitalizations and mortality in children 3 - 24-month-old in Nigeria from 2013 to 2020: Impact of pneumococcal conjugate vaccine ten valent (PHiD-CV-10)

• Main Authors: Jalo Iliya (Author), Denis R. Shatima (Author), Beckie N. Tagbo (Author), Adejumoke I. Ayede (Author), Abieyuwa O. Fagbohun (Author), Aliu Rasaq (Author), Sarah Nalban (Author), Isaac W. Elon (Author), Ramatu Mohammed-Nafiu (Author), Patience Ahmed (Author), Oladapo B. Oyewole (Author), Ayobami A. Bakare (Author), Bidemi O. Yusuf (Author), Olugbenga O. Akinrinoye (Author), William N. Ogala (Author), Adegoke G. Falade (Author)
• Format: Book
• Published: Taylor & Francis Group, 2023-01-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Pneumococcal conjugate vaccine ten valent (PCV 10) was introduced into Nigeria in three phases. Phase 3 introduction started in August 2016. However, its impact on pneumonia admissions and mortality among vaccinated Nigerian children has not been determined. Data in the period before PCV-10 introduc...